ArticlePDF Available

Neural Tube Defects; Clinical Patterns, Associated Risk Factors and Maternal Awareness in Khartoum State, Sudan

Authors:

Abstract and Figures

Neural Tube Defects account for one of the most common birth defects and are associated with a high mortality, morbidity and life-long disability. The main objective of this research was to determine maternal risk factors, the most common clinical presentations of neural tube defects and assess maternal awareness on folic acid supplementation and its preventive role in the occurrence of neural tube defects.This was an observational hospital-based case finding study that covered 91 patients with neural tube defects and their respective mothers conducted in the main hospitals of Khartoum state from September 2011 to February 2012. Questionnaires were filled in the form of interviews and the patients were examined to determine the clinical presentation of the neural tube defects. The results showed that experiencing any febrile illness (p=<0.001), taking medications (p= <0.001) during pregnancy and consanguinity (p=<0.001) have been associated with the birth of a fetus with a neural tube defect. 42.9% of all NTDs were myelo-meningoceles and 73.3% of all NTDs were lumbo-sacral in location. 61.5% of NTDs were associated with hydrocephalus and 50.5% had lower limb weakness. Only 14.3% of mothers were aware of the preventive role offolic acid in the development of neural tube defects. In conclusion the study emphasizes the complexity of the etiology behind neural tube defects, variability of its presentation and yet unsatisfactory awareness among Sudanese mothers about folic acid and its benefits regarding neural tube defects. Keywords: Neural tube defects; folic acid; consanguinity, Sudan.
No caption available
… 
Content may be subject to copyright.
Journal of Medicine and Medical Research
Vol. 3(1): 1-6, March, 2015
ISSN: 2350-1502
www.resjournals.org/JMMR
Neural Tube Defects; Clinical Patterns, Associated Risk
Factors and Maternal Awareness in Khartoum State,
Sudan
Abdelmoneim E.M. Kheir
1
and Wala M. H. Eisa
2
1
Department of Paediatrics and Child Health, Faculty of Medicine, University of Khartoum, Sudan
2
Department of Paediatrics, the University of Medical Sciences and technology. Sudan
Email for Correspondence: moneimkheir62@hotmail.com
Abstract
Neural Tube Defects account for one of the most common birth defects and are associated with a high
mortality, morbidity and life-long disability. The main objective of this research was to determine
maternal risk factors, the most common clinical presentations of neural tube defects and assess
maternal awareness on folic acid supplementation and its preventive role in the occurrence of neural
tube defects.This was an observational hospital-based case finding study that covered 91 patients with
neural tube defects and their respective mothers conducted in the main hospitals of Khartoum state
from September 2011 to February 2012. Questionnaires were filled in the form of interviews and the
patients were examined to determine the clinical presentation of the neural tube defects. The results
showed that experiencing any febrile illness (p=<0.001), taking medications (p= <0.001) during
pregnancy and consanguinity (p=<0.001) have been associated with the birth of a fetus with a neural
tube defect. 42.9% of all NTDs were myelo-meningoceles and 73.3% of all NTDs were lumbo-sacral in
location. 61.5% of NTDs were associated with hydrocephalus and 50.5% had lower limb weakness. Only
14.3% of mothers were aware of the preventive role offolic acid in the development of neural tube
defects. In conclusion the study emphasizes the complexity of the etiology behind neural tube defects,
variability of its presentation and yet unsatisfactory awareness among Sudanese mothers about folic
acid and its benefits regarding neural tube defects.
Keywords: Neural tube defects; folic acid; consanguinity, Sudan.
INTRODUCTION
Neural tube defects (NTDs) are one of the most common birth defects, affecting over 300,000 births globally each year,
They exhibit a marked geographical variation, with the incidence higher in Great Britain and lower in Japan (Marks et
al.1998). Indian and Eastern Mediterranean populations also have relatively high incidences of NTDs, However, unlike
the Western white populations, anencephaly is more common than spinabifida (Saxena et al. 2013).
The incidence of neural tube defects (NTDs) in developing countries has been reported to be up to four-fold higher
than in developed ones (Cherian et al.2005), this may be due to the absence of preconceptional counselling coupled
with suboptimal antenatal care services. (Adeleye et al. 2010).
Neural tube defects (NTD) occur because of a defect in the neurulation process. Since the anterior and posterior
neuropores close last, they are the most vulnerable to defects. Consequently, a majority of NTDs arise in these areas.
NTDs can be classified, based on embryological considerations and the presence or absence of exposed neural tissue,
as open or closed types (Dias et al.1998, Dirks et al.1999).
2
Over the years, epidemiologic studies have tried to determine the etiology behind NTDs. Certain genetic and
environmental factors have been found to affect the occurrence of NTDs. However, there is a strong link between folic
acid deficiency and the occurrence of NTDs (Salvi, 2003). To date, few specific environmental causes of neural-tube
defects have been recognized,such as maternal diabetes (Becerra et al.1990) and maternal use of some antiepileptic
drugs, such as valproic acid. (Lammer et al.1987) Other factors, including fever and hyperthermia in early pregnancy
(Graham et al.1998) and obesity (Shaw et al.1996), have been proposed.
Treatments of NTDs depends on the severity of the complication. No treatment is available for anencephaly and
infants usually do not survive more than a few hours. Aggressive surgical management has improved survival and the
functions of infants with spina bifida, meningoceles and mild myelomeningoceles (Walters et al.1997).Neural tube
defects resulted in 71,000 deaths globally in 2010 (Lonzano, 2012).
In Africa, the reported incidence of spina bifida is variable, e.g. in Malawi it was 0.47/1000, in Cape Town the
prevalence of NTDs was 1.74/1000, however in Sudan the incidence was 3.48/1000 which is the highest reported in
Africa so far (Masmati et al.2000, Viljoen et al.1995, Elsheikh et al.2009).
The objectives of this study were; determining the clinical presentations of NTDs, determining different maternal risk
factors for the occurrence of NTDs (age, consanguinity, febrile illnesses, diabetes mellitus, medications), and assessing
maternal awareness on folic acid supplementation and its preventive role in the occurrence of NTDs. There is strong
need to conduct this study in Sudan as NTDS are on the increase and there is gap in knowledge among mothers
regarding the preventive role of folic acid supplementation.
MATERIALS AND METHODS
Study design and data collection
This was a prospective, observational, hospital based study that was conducted in the main hospitals of Khartoum state,
the capital of Sudan, during the period September 2011 to February 2012.The study included all patients born with
NTDs and their respective mothers. All new borns (alive and stillbirths) diagnosed as having a neural tube defects during
the study period were included in the study. The dependent variable was Neural tube defects and the independent
variables were age of mother, febrile illness during pregnancy, medication taken during pregnancy,maternal diabetes,
family history for neural tube defects and Folic acid supplementation. Ninety one babies were included in the study. New
borns were examined by a consultant paediatrician or a senior paediatric registrar to determine the pattern of NTDs and
associated anomalies. Data was obtained in the form of questionnaires, all mothers were met and personal interviews
were conducted using a specifically designed questionnaire for collecting the required data.
Simple descriptive statistics, frequency distributions and cross tabulation were performed on Statistical Package for
Social Sciences (SPSS) software version 17.The results were tested for association using chi-square between maternal
wellbeing and NTDs. Level of significance was set on an alpha level at 0.05.Ethical clearance and approval for
conducting this study was obtained from the ethical committees of the main hospitals in Khartoum state. Prior informed
verbal consent was obtained from the parents of the babies participating in this study after full explanation of the study.
RESULTS
In this prospective study ninety one babies with NTDs were detected in Khartoum state during the study period.
Classification of the mothers according to age showed that 40 (44%) of them were falling in the age group (26 35)
years, whereas 36 (39.6%) were falling in the age group (15 25) years and 15 (16.5%) were between 36-45 years.
When the mothers were classified according to their level of education, it was noticed that 23 (25.3%) of them were
found to have secondary education, whereas 21 (23.1%) were found to have basic education and 19 (20.9%) were
university graduates with an illiteracy rate of 13.2%. The study showed that the majority of the mothers (89.1%) were
unemployed (house wives) and 47 (51.6%) of the respondents were found to have regular visits to antenatal care
centers.When the respondents were inquired about experiencing any form of febrile illness during pregnancy (specially
the first trimester), 27(29.7%) of them reported so. More details revealed that 10 (37%) described a flu-like illness,
whereas 5 (18.5%) reported malaria. Table (1).
The study showed that only one out of the total number of subjects was found to have gestational diabetes, whereas
61 (67%) did not check their blood glucose levels during pregnancy. 26 (28.6%) of the mothers reported taking
medications during pregnancy. 5 (19.2%) mentioned antiemetics, 3 (11.5%) NSAID (paracetamol / aspirin) whereas 6
(23.1%) mentioned antibiotics. Table (2). None of the respondents was found to have been exposed to any form of
radiation during pregnancy. The study showed that 41 (45.1%) of the mothers were taking folic acid during pregnancy.
3
Table 1. Febrile illness during pregnancy.
Frequency
Percent
flu-like illness
10
37.0
Malaria
5
18.5
fever + skin rash
3
11.1
Gastroenteritis
1
3.7
Other
8
29.6
Total
27
100.0
Table 2. Type of medication during pregnancy.
Frequency
Percent
NSAID* (paracetamol / asprin)
3
11.5
Anti-emetics
5
19.2
Calcium supplements
1
3.8
Herbal
4
15.4
Antibiotics
6
23.1
Other
7
26.9
Total
26
100
*NSAID; Steriodal anti-Inflammatory drugs
Table 3. Associated congenital anomalies
Frequency
Percent
Cardiovascular
3
13.6
Respiratory
1
4.5
Renal
1
4.5
Musculoskeletal
6
27.3
Hernia
4
18.2
Other
7
31.8
Total
22
100
Regarding the timing of folic acid consumption during pregnancy, 23(56,1%) started folic acid during the second
trimester and only one woman (2.4%) took folic acid preconception. Figure 1.
When the respondents were asked if they are aware that folic acid supplementation reduces the risk of developing
neural tube defects, it was found that 13 (14.3%) of them were aware of that.
None of the respondents was found to have given birth to a child with a neural tube defect, however, 54 (59.4%) of the
mothers reported consanguinity with their husbands and only one out of the total number of the subjects reported a
positive family history of NTDs. 23 (25.3%) of the cases were diagnosed antenataly. The study showed that 61(67%) of
the cases were delivered by normal spontaneous vaginal delivery whereas 30(33%) by caesarian section. The study
demonstrated that 56(61.5%) of the subjects were females and 35(38.5%) were males, moreover 87(95.6%) were term
and 4 (4.4%) were preterm. Classification of the babies according to the type of neural tube defect, showed that 39
(42.9%) of them were found to have myelomeningocele, 35 (38.5%) were found to have meningocele, 16(17.6%) had
encephalocele and only one baby (1.1%) out of the total number had anencephaly. Examination for the location of the
neural tube defect revealed that 55 (73.3%) of the cases were Lumbo-sacral whereas 10 (13.3%) were Lumbar,
8(10.8%) were sacral and only one (1.35%) in the thoracic region.
Examination for associated anomalies showed that hydrocephalus was present in 56(61.5%) of the total subjects,
lower limb weakness in 46(50.5%) and foot deformity in 10(11%) Other associated anomalies outside the central
nervous system are shown in table 3.
4
Discussion
This study was conducted in the main hospitals of Khartoum state with the main objective of determining maternal risk
factors associated with NTDs. The study showed that almost 84% of the study subjects were at the age group (15-35)
years which is considered to be an indication of a young generation. This result actually complements a study conducted
in Omdurman Hospital in Sudan where the majority of mothers were found to be younger than 25 years of age
(Elsheikhet al.2009).The education level of the study subjects is somewhat satisfactorywith an illiteracy rate of 13.2%
and is expected to play an essential role in enhancing the level of knowledge and attitude of those mothers towards
NTDs. 89.1% of the mothers included in this study were unemployed. This can be related to the fact that only 20.9% of
them were University graduates.
The study showed that 51.6% of the respondents have attended regular antenatal care; yet this did not affect the
outcome significantly. This fact may be attributed to the possibility that the antenatal care clinics they attended might
have been poorly equipped and did not investigate the mothers thoroughly.
Experiencing any febrile illness and taking medication during pregnancy were found to have significant association
with the occurrence of NTDs (p=<0.001). As for febrile illness the majority described acquiring a flu-like illness (37%) or
malaria (18.5%). This result supports the findings of previous studies that also found fever and hyperthermia
experienced in early pregnancy as a risk factor for the development of neural tube defects (Graham et al.1998). As for
medications that were used prior to the pregnancy and during the first trimester, most mothers reported taking antibiotics
(23.1%) or NSAID (11.5%). Previous studies have established the direct teratogenic effect of anti-epileptic medications
such as valporic acid in causing NTDs(Lammeret al.1987). However, the role of antibiotics and NSAID have not yet
been clearly established as teratogens.
The fact that the majority of the mothers were not screened for any form of diabetes may be attributed to the
affordability of the investigations and poor antenatal care. Diabetes cannot be considered as risk factor among this
group of mothers, since only one was a diabetic and most respondents didn’t have their blood glucose checked. As
mentioned before, diabetes is a well- established risk factor for the development of NTDs (Becerra et al.1990),
regardless of the inconclusive results of this study.
Our study showed insignificant association between consumption of folic acid and development of NTDs (P =0.345).
Almost half (45.1%) of the respondents reported taking folic acid, however, 56.1% of the mothers who did take folic
acid took it in their 2nd trimester, moreover 70.1% of the mothers did not take folic acid regularly during their pregnancy
due to poor compliance. It can be clearly concluded that the true potential of folic acid in preventing NTDs cannot be
accurately assessed in this group of mothers. This makes it difficult to draw any conclusions about the role of folic acid
in the development of NTDs. Regardless, most of the studies advocate the use of folic acid during pregnancy as a form
5
of primary prevention of NTDs, Folic acid taken by women at least four weeks prior to conception and throughout the
first trimester of pregnancy, or periconceptional intake, has been associated with up to 80% reduction in the incidence of
NTDs. (Czeizel et al.1992). A 19% reduction in NTD birth prevalence occurred following folic acid fortification of the
United States food supply. However, factors other than fortification may have contributed to this decline(Honeinet
al.2001).
Almost 86% of the study subjects were not aware that folic acid supplementation reduces the risk of developing NTDs.
This was found to be the universal state of the mothers regardless of their educational status. This is in agreement with
the Nigerian study where most of the respondents did not know the beneficial effect of Folic acid in reducing the risk of
NTDs (Lawalet al.2014).
In our study consanguinity has been found to be a risk factor for the development of NTDs (p=<0.001). 59.4% of the
mothers were indeed related to their husbands and 49.5% of them were direct first degree relatives. This may indicate
the complex genetic role behind the etiology of NTDs. This is in agreement with a study done in India where NTDs were
significantly higher among babies born to parents of consanguineous marriage (P=0.01) (Mahadevanet al.2005).
Our study showed that 56(61.5%) of the subjects were females and 35(38.5%) were males, with females more
affected that males. This is in agreement with many other studies, however no genuine explanation could be offered for
this gender preponderance. (Masmati et al.2000, Gaigi et al.2000, Viljoen et al.1995 ).
In this study 56(61.5%) of all NTDs were associated with the presence of hydrocephalus, which is similar to many
other previous studies (Nielsen et al.2006, Cate et al.2002, Northrup et al.2000). Almost half (50.5%) of all fetuses with
NTDs suffered from lower limb weakness and this is usually permanent in most cases. 24.2% of NTDs were associated
with other anomalies, most were musculoskeletal in origin (27.3%). This clearly shows that NTDs are almost always
associated with other anomalies of one form or another increasing the morbidity and mortality of NTDs.
Conclusion
Neural tube defects account for one of the most common birth defects. Experiencing any febrile illness, taking
medications during pregnancy and consanguinity have been associated with increased risk of birth of a fetus with a
neural tube defect. The study emphasizes the complexity of the etiology behind neural tube defects, variability of its
presentation and yet unsatisfactory awareness among Sudanese mothers about folic acid and its beneficial role in
preventing neural tube defects.
Acknowledgement
The authors express their sincere appreciation to the boards of administration of the main hospitals in Khartoum state
for giving their approval and assistance in conducting this research. In addition, the authors are grateful to the mothers
who participated willingly in this study.
References
Adeleye AO., Dairo MD and Olowookere KG (2010). Central nervous system congenital malformations in a developing
country: issues and challenges against their prevention. Childs NervSyst; 26(7):919-924
Becerra JE., Khoury MJ, Cordero JF and Erickson JD (1990). Diabetes mellitus during pregnancy and the risks for
specific birth defects: a population-based case-control study. Pediatrics ; 85:1-9
Cate IM., Kennedy C and Stevenson J (2002). Disability and quality of life in spina bifida and hydrocephalus. Dev Med
Child Neurol. ; 44(5):317-22
Cherian A., Seena S., Bullock RK and Antony AC (2005). Incidence of neural tube defects in the least-developed area of
India: a population-based study. Lancet ; 366(9489):930-93
Czeizel AE and Dudas I (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin
supplementation. N Engl J Med ; 327(26):1832-1835
Dias MS and Li V (1998). Pediatric neurosurgical disease. PediatrClin North Am ; 45(6):1539-78
Dirks PB and Rutka JT (1999). Theneurogenetic basis of pediatric neurosurgical conditions. In: Albright L, Pollack I,
Adelson D, eds. Principles and Practice of Neurosurgery. New York: Thieme Medical Publishers; 23-4
Elsheikh GE and Ibrahim SA (2009). Neural Tube defects in Omdurman Maternity Hospital, Sudan. Khartoum Medical
Journal; 2: 185 -190
Gaigi SS., Masmoudi A and Mahjoub S (2000). Fetal pathology study of 88 cases of lethal spina bifida. Tunis Med J; 78:
727-30.
6
Graham JM., Edwards MJ and Edwards MJ (1998). Teratogen update: gestational effects of maternal hyperthermia due
to febrile illnesses and resultant patterns of defects in humans. Teratology ; 58:209-221
Honein MA., Paulozzi L J., Mathews TJ., Erickson JD and Wong LY (2001). Impact of Folic Acid Fortification of the US
Food Supply on the Occurrence of Neural Tube Defects; JAMA ; 285: 2981-2986
Lammer EJ., Sever LE and Oakley GP (1987). Teratogen update: valproic acid. Teratology ; 35:465-473
Lawal TA and Adeleye AO (2014). Determinants of folic acid intake during preconception and in early pregnancy by
mothers in Ibadan, Nigeria. The Pan African Medical Journal; 19:113
Lozano R (2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a
systematic analysis for the Global Burden of Disease Study 2010.” Lancet ; 380 (9859): 2095–128
Mahadevan B and Vishnu BB (2005). Neural Tube Defects in Pondicherry. Indian Journal of Pediatrcis; 72:557-559
Marks JD and Khoshnood B (1998). Epidemiology of common neurosurgical diseases in the neonate. NeurosurgClin N
Am ; 9(1):63-72
Masmati BC., Igbigbi PS and Chisi JE (2000) The Incidence of cleft lip, cleft palate, hydrocephalus and spina bifida at
Queen Elizabeth Central Hospital, Blantyre, Malawi. Cent Afr J Med; 46: 292-96
Nielsen LA., Maroun LL, Broholm H., Laursen H and Graem N (2006). Neural tube defects and associated anomalies in
a fetal and perinatal autopsy series. APMIS. ; 114(4):239-46
Northrup H and Volcik KA (2000). Spina bifida and other neural tube defects. CurrProblPediatr. ; 30(10):313-32
Salvi VS (2003 ). Folic acid and birth defects. J Post grad Med ; 49:195-96
Saxena AK., Pandey S and Pandey LK (2013) Genetic diversity of stem cells and their functional impact on the
development of neural tube defects in Eastern population of India. Genet Mol Res; 12(3):2380-90
Shaw GM., Velie EM and Schaffer D (1996). Risk of neural tube defect-affected pregnancies among obese women.
JAMA ; 275:1093-1096
Viljoen DL., Buccimazza S., Dunne T and Molteno C (1995). The prevalence and prevention of neural tube defects in
Cape Town. Afr Med J; 85: 630-32
Walters J., Ashwal S and Masek T (1997) Anencephaly: where do we now stand? SeminNeurol ; 17(3):249-55
... Les anomalies de fermeture du tube neural représentent 5 % des malformations congénitales [18]. On estime que plus de 300 000 cas de MTN surviennent par an dans le Monde, surtout dans les pays à faible revenu [1,19]. La fréquence du spina bifida et de l'encéphalocèle est estimée à 1/1000 grossesses en France [16]. ...
... Le spina bifida est considéré comme une anomalie multifactorielle résultant de l'interaction de divers facteurs en particulier génétiques [1,4,9,12,18,21,22,25]. Les mécanismes moléculaires impliqués la genèse de la malformation ne sont pas encore bien compris [4]. ...
... L'incidence des anomalies de fermeture du tube neural varie entre 3 et 40 cas pour 10 000 au Maroc [18]. L'incidence des anomalies du tube neural serait quatre fois plus élevée dans les pays en développement par rapport aux pays développés [7] du fait de l'absence de conseil préconceptionnel associé avec des services de soins prénatals sous-optimaux [1,2]. La fréquence annuelle de spina bifida (10,6 cas/an) dans notre étude est probablement sous-estimée car il s'agit d'une fréquence hospitalière partielle (département de pédiatrie du CHUSS) qui n'est pas représentative de la population générale de la région. ...
... Neural tube defect (NTD) is related to failure of neural tube closure between 3 rd and 4 th weeks of embryo development [1]. The cause of NTDs is not clearly stated, however, many factors like radiation, drugs, malnutrition, chemicals, genetic, maternal age, previous history of still birth, lack of Antenatal Care (ANC), consanguinity and any febrile illness during pregnancy were identified as contributors for development of NTDs [2][3][4]. ...
... In Ethiopia the prevalence of birth defect is 19 per 1000 births from which 30.87% is attributable to NTDs, which is the second common cause of birth defect [3,17]. According to study done in two teaching hospitals in Addis Ababa, Ethiopia, the prevalence of neural tube defect is higher (6.1/1000 births) than reports from different studies in African countries [15,16,18]. ...
Article
Full-text available
Introduction: Neural Tube Defect (NTD) is related to failure of neural tube closure between 3 rd and 4 th weeks of embryo development. The cause of NTDs is not clearly stated, however, may factors like radiation, drugs, malnutrition, chemicals, genetic, maternal age, previous history of still birth, lack of Antenatal Care (ANC), consanguinity and any febrile illness during pregnancy were identified as contributing factors for development of NTDs. In spite of deficiency of folic acid in Ethiopia, data on factors of NTD were very limited in Africa in general and Ethiopia in particular, therefore this study was undertaken to identify associated factors with NTDs and provides shadow for future studies.
... For example, in a Tanzanian study, NTDs were the most common congenital anomalies among significant external structural defects, affecting 1 in 1000 births [11]. NTDs are the second leading cause of birth defects in Ethiopia, where the prevalence of congenital disabilities reaches 19 per 1000 births [2,6,[13][14][15]. Different studies found varying rates of NTDs. ...
Article
Full-text available
Abstract Background Neural tube defects (NTDs) are serious brain and spine birth defects. Although NTDs are primarily pregnancy complications, such as abortion and stillbirth, they also contribute to under-five morbidity and mortality, as well as long-term disability and psychological impact. Despite these negative outcomes, the determinants of NTDs are not widely studied in Ethiopia, particularly in the country’s east. As a result, we sought to identify the risk factors for NTDs in neonates born in public referral hospitals in eastern Ethiopia. Methods A facility-based unmatched case-control study was carried out at Hiwot Fana Comprehensive Specialized Hospital and Sheik Hassen Yabare Jigjiga University Referral Hospital in Eastern Ethiopia. We included 59 cases identified in the selected facilities between September 10, 2021, and February 5, 2022, and 118 control neonates, with a case-to-control ratio of 1:2. Data were gathered through the use of interviewer-administered questionnaires and medical record review. To identify determinant factors of NTDs, a multivariable logistic regression model was used, which included all predictor variables from the bivariable analysis. The results were reported using an Adjusted Odds Ratio (AOR) with a 95% confidence interval. A p-value of
... were females. The majority were females in the present study, the literature also showed that anencephaly is more common in females [7,8]. ...
Article
Full-text available
Introduction: Anencephaly accounts for one of the most common birth defects & is associated with a high mortality & morbidity. The objective was to determine frequency of anencephaly and its associated anomalies, risk factors, clinical presentations & assess maternal awareness on folic acid supplementation and its preventive role in occurrence of anencephaly. Materials and Methods: The study includes 60 anencephalic fetuses (23 males & 37 females) of 20-30 weeks. The fetuses were examined for external abnormalities & dissected. Measurements of crown heel, crown rump, head circumference, foot length, & weight were taken. All the major organs were weighed & data recorded. The samples were fixed with 10% buffered formaldehyde. The internal anomalies were noted. Results: The number of deliveries was 57429 deliveries. 23(38.4%) were males & 37(61.6%) were females. The frequency of anencephaly in 2014 was 15134/9 (0.06%), in 2015 16361/21 (0.13%). Weight of 40% were <500gms, 35% were between 500-1000gms & 25% <1000. Maternal age in 83.4% were 21-35 years, in <20 years & >40 years were 1.6% & in 36-40 years were 13.4%. Associated anomalies were present in 42 (70%) fetuses. Out of 42 fetuses, those who had associated anomalies were 17 (40.4%) males and 25 (59.6%) were females. All the fetuses had Acrania (100%) & 19 (45.3%) fetuses had spina bifida; there were no anomalies found in reproductive system. Conclusion: 4mg of folic acid should be taken before 6 months of conceiving & during the entire pregnancy. In order to prevent the anencephaly and associated anomalies certain maternal risk factors should be avoided as prescribed by gynecologist. KEY WORDS: Anencephaly, Crown Heel, Crown Rump, Head Circumference, Foot Length, Weight
... Literature showed that anencephaly is more common in females 6,7 . In the present study, 23(38.4%) ...
Article
Full-text available
Anencephaly: Incidence, Risk Factors and Biochemical Analysis of Mother
... Singh 11 The study showed that 100% of cases cerebrum& cerebellum of non-anencephalic foetuses had all the normal layers. In anencephalic foetuses, cerebrum in 75% cases showed primitive brain cells, astrocytes & glial cells, instead of 5 layers which was described in checklist & in 25 % cases angiomatous masses were seen but primitive brain cells & astrocytes were absent. ...
... Literature showed that anencephaly is more common in females 6,7 . In the present study, 23(38.4%) ...
... were females. The majority were females in the present study, the literature also showed that anencephaly is more common in females [7,8]. ...
... Therefore, we present a few available statistics on this etiological aspect of NTDs in Table 1 of this letter. 1,3,6 Of particular interest to note is the same marked contrast of our local observations in Africa with the previously published statistics presented by Dupépé et al. The established prevalence of family history of NTDs at our center in Nigeria is in fact 0.9% 1 (Table 1), though we have not noticed any significant change in positive family history from unpublished data of our more recent research. ...
Article
Full-text available
In order to identify targets for primary preventive strategies, we explored possible predictors of periconceptional folic acid (pFA) intake in a Nigerian population of reproductively active women. A cross sectional study of mothers attending immunization clinics at two hospitals was conducted between May and November 2012. Information obtained included sociodemographic and obstetric details and periconceptional usage of FA. Independent variables were analysed as predictors of pFA intake using chi-square statistical test and multinomial logistic regression. The study involved 602 mothers aged 17 to 42 years; 23% had a university degree and 66% were in the working class. Preconceptional usage was proven in only 15 (2.5%). Periconceptional usage was more likely among professionals (X(2) = 41.194, p < 0.001), have university degree (X(2) = 53.089, p < 0.001), be primigravid (X(2) = 18.415, p < 0.001) and early antenatal clinic attendees (X(2) = 355.9, p < 0.001). Women were less likely to know that FA could prevent birth defects if in the working class (1.7% vs. 11.1%, X(2) = 25.593, p < 0.001), less educated (0.5 vs. 10.9%, X(2) = 38.083, p < 0.001) or booked late for antenatal care (2.0 vs. 5.9%, X(2) = 5.767, p = 0.016). The determinants of late commencement of FA were low social class (OR = 4.29, 95% CI: 1.59, 11.31), lack of university education (OR = 4.58, 95% CI: 3.06, 6.87) and late booking (OR = 104.27, 95% CI: 53.09, 204.76). In this population of reproductively active women, pFA intake and knowledge of its health benefits are poor amongst mothers - in working class, with limited education, and who present late for antenatal care.
Article
Full-text available
Background: Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex. Methods: We attempted to identify all available data on causes of death for 187 countries from 1980 to 2010 from vital registration, verbal autopsy, mortality surveillance, censuses, surveys, hospitals, police records, and mortuaries. We assessed data quality for completeness, diagnostic accuracy, missing data, stochastic variations, and probable causes of death. We applied six different modelling strategies to estimate cause-specific mortality trends depending on the strength of the data. For 133 causes and three special aggregates we used the Cause of Death Ensemble model (CODEm) approach, which uses four families of statistical models testing a large set of different models using different permutations of covariates. Model ensembles were developed from these component models. We assessed model performance with rigorous out-of-sample testing of prediction error and the validity of 95% UIs. For 13 causes with low observed numbers of deaths, we developed negative binomial models with plausible covariates. For 27 causes for which death is rare, we modelled the higher level cause in the cause hierarchy of the GBD 2010 and then allocated deaths across component causes proportionately, estimated from all available data in the database. For selected causes (African trypanosomiasis, congenital syphilis, whooping cough, measles, typhoid and parathyroid, leishmaniasis, acute hepatitis E, and HIV/AIDS), we used natural history models based on information on incidence, prevalence, and case-fatality. We separately estimated cause fractions by aetiology for diarrhoea, lower respiratory infections, and meningitis, as well as disaggregations by subcause for chronic kidney disease, maternal disorders, cirrhosis, and liver cancer. For deaths due to collective violence and natural disasters, we used mortality shock regressions. For every cause, we estimated 95% UIs that captured both parameter estimation uncertainty and uncertainty due to model specification where CODEm was used. We constrained cause-specific fractions within every age-sex group to sum to total mortality based on draws from the uncertainty distributions. Findings: In 2010, there were 52·8 million deaths globally. At the most aggregate level, communicable, maternal, neonatal, and nutritional causes were 24·9% of deaths worldwide in 2010, down from 15·9 million (34·1%) of 46·5 million in 1990. This decrease was largely due to decreases in mortality from diarrhoeal disease (from 2·5 to 1·4 million), lower respiratory infections (from 3·4 to 2·8 million), neonatal disorders (from 3·1 to 2·2 million), measles (from 0·63 to 0·13 million), and tetanus (from 0·27 to 0·06 million). Deaths from HIV/AIDS increased from 0·30 million in 1990 to 1·5 million in 2010, reaching a peak of 1·7 million in 2006. Malaria mortality also rose by an estimated 19·9% since 1990 to 1·17 million deaths in 2010. Tuberculosis killed 1·2 million people in 2010. Deaths from non-communicable diseases rose by just under 8 million between 1990 and 2010, accounting for two of every three deaths (34·5 million) worldwide by 2010. 8 million people died from cancer in 2010, 38% more than two decades ago; of these, 1·5 million (19%) were from trachea, bronchus, and lung cancer. Ischaemic heart disease and stroke collectively killed 12·9 million people in 2010, or one in four deaths worldwide, compared with one in five in 1990; 1·3 million deaths were due to diabetes, twice as many as in 1990. The fraction of global deaths due to injuries (5·1 million deaths) was marginally higher in 2010 (9·6%) compared with two decades earlier (8·8%). This was driven by a 46% rise in deaths worldwide due to road traffic accidents (1·3 million in 2010) and a rise in deaths from falls. Ischaemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lower respiratory infections, lung cancer, and HIV/AIDS were the leading causes of death in 2010. Ischaemic heart disease, lower respiratory infections, stroke, diarrhoeal disease, malaria, and HIV/AIDS were the leading causes of years of life lost due to premature mortality (YLLs) in 2010, similar to what was estimated for 1990, except for HIV/AIDS and preterm birth complications. YLLs from lower respiratory infections and diarrhoea decreased by 45-54% since 1990; ischaemic heart disease and stroke YLLs increased by 17-28%. Regional variations in leading causes of death were substantial. Communicable, maternal, neonatal, and nutritional causes still accounted for 76% of premature mortality in sub-Saharan Africa in 2010. Age standardised death rates from some key disorders rose (HIV/AIDS, Alzheimer's disease, diabetes mellitus, and chronic kidney disease in particular), but for most diseases, death rates fell in the past two decades; including major vascular diseases, COPD, most forms of cancer, liver cirrhosis, and maternal disorders. For other conditions, notably malaria, prostate cancer, and injuries, little change was noted. Conclusions: Population growth, increased average age of the world's population, and largely decreasing age-specific, sex-specific, and cause-specific death rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes towards non-communicable diseases. Nevertheless, communicable, maternal, neonatal, and nutritional causes remain the dominant causes of YLLs in sub-Saharan Africa. Overlaid on this general pattern of the epidemiological transition, marked regional variation exists in many causes, such as interpersonal violence, suicide, liver cancer, diabetes, cirrhosis, Chagas disease, African trypanosomiasis, melanoma, and others. Regional heterogeneity highlights the importance of sound epidemiological assessments of the causes of death on a regular basis. Funding: Bill & Melinda Gates Foundation.
Article
Full-text available
Little efforts are geared towards prevention of CNS anomalies in the developing countries. A 1-year prospective cross-sectional analysis of the cases of CNS congenital anomalies seen in a Nigerian neurosurgical unit. This included both the children's and parents' sociodemographics, the profiles of the CNS anomalies, and the maternal obstetric health behaviors toward primary and/or secondary prevention of the anomalies. Statistical analysis was done with the Pearson's chi-square (or Fishers' exact) test. Level of significance set at P < 0.05. There were 54 cases of cranial and spinal gross CNS anomalies, including 32 neural tube defects; two thirds of the parents were low-income earners, and half had only basic education. Thirty percent of the pregnancies were unbooked; the mean gestational age (GA) at booking and commencement of obstetric micronutrient supplementation was 4.6 months. No case had periconceptional folic acid supplementation. Obstetric ultrasonography was performed late in pregnancy (mean GA 6 months), made positive diagnosis of CNS anomaly in only 14%, and was performed mainly in unsupervised private clinic settings in 98%. Little or no attention is currently paid to the prevention of CNS congenital anomalies in much of the low- and middle-income countries of the world. There is a great need to regulate the practice of obstetric ultrasonography in Nigeria. There is even a much greater, more fiercely urgent need to ensure periconceptional folic acid supplementation for all women of childbearing age through appropriate food fortification in these societies.
Article
Full-text available
The risk of recurrent neural-tube defects is decreased in women who take folic acid or multivitamins containing such during the periconceptional period. The extent to which folic acid supplementation can reduce the first occurrence of defects is not known. We conducted a randomized, controlled trial of periconceptional multivitamin supplementation to test the efficacy of this treatment in reducing the incidence of a first occurrence of neural-tube defects. Women planning a pregnancy (in most cases their first) were randomly assigned to receive a single tablet of a vitamin supplement (containing 12 vitamins, including 0.8 mg of folic acid; 4 minerals; and 3 trace elements) or a trace-element supplement (containing copper, manganese, zinc, and a very low dose of vitamin C) daily for at least one month before conception and until the date of the second missed menstrual period or later. Pregnancy was confirmed in 4753 women. The outcome of the pregnancy (whether the fetus or infant had a neural-tube defect or congenital malformation) was known in 2104 women who received the vitamin supplement and in 2052 who received the trace-element supplement. Congenital malformations were significantly more prevalent in the group receiving the trace-element supplement than in the vitamin-supplement group (22.9 per 1000 vs. 13.3 per 1000, P = 0.02). There were six cases of neural-tube defects in the group receiving the trace-element supplement, as compared with none in the vitamin-supplement group (P = 0.029). The prevalence of cleft lip with or without cleft palate was not reduced by periconceptional vitamin supplementation. Periconceptional vitamin use decreases the incidence of a first occurrence of neural-tube defects.
Article
Anencephaly and myelomeningocele are the 2 most common forms of neural tube defects (NTDs). During embryogenesis large numbers of extrinsic and intrinsic factors are responsible for the closing of the neural tube. "Stem cells" maintain the pluripotency during differentiation of 3 germ layers, including the neural ectoderm. We examined the role of Oct4, Nanog3, and Sox2 genes in the etiopathology of NTDs in an eastern Indian population using PCR-based DNA analysis. The highest frequency (16%) of complete loss of the Sox2 gene was found in NTDs. The highest frequency (48%) of overexpression (upregulation) was found for Nanog3, while 40% was observed for Oct4 and Sox2. The odds ratio for cases versus controls was from 0.132 at 95% confidence interval = 0.005-1.298 for Nanog3 to 2.316 (0.424-13.812) for Oct4. The highest frequency (77%) of overexpression for Nanog3 and Sox2 was observed in encephalocele and anencephalic patients, while in the comparison of regional variation, i.e., cephalic to caudal regions of NTDs, the highest frequency of downregulation (regression) of Nanog3 and Sox2 was found in lumbosacral myelomeningocele patients. However, cervical myelomeningocele patients had the highest frequency of overexpression in all 3 genes, suggesting that the mutational spectra of stem cells influence the cells of the neural crest in NTDs.
Article
Although the excess risk for birth defects among children of mothers with diabetes mellitus is well documented, there are few data concerning the risk for specific malformations. In the Atlanta Birth Defects Case-Control Study, those risks for malformations were evaluated. The population-based study included 4929 live and stillborn babies with major malformations ascertained by the Metropolitan Atlanta Congenital Defects Program in the first year of life born to residents of Metropolitan Atlanta between 1968 and 1980. The study also included 3029 nonmalformed live babies who were frequency-matched to case babies by race, period of birth, and hospital of birth. The relative risk for major malformations among infants of mothers with insulin-dependent diabetes mellitus (n = 28) was 7.9 (95% confidence interval [CI]1.9, 33.5) compared with infants of nondiabetic mothers. The relative risks for major central nervous system and cardiovascular system defects were 15.5 (95% CI = 3.3, 73.8) and 18.0 (95% CI = 3.9, 82.5), respectively. The absolute risks for major, central nervous system, and cardiovascular system malformations among infants of diabetic mothers were 18.4, 5.3, and 8.5 per 100 live births, respectively. Infants of mothers with gestational diabetes mellitus who required insulin during the third trimester of pregnancy were 20.6 (95% CI = 2.5, 168.5) times more likely to have major cardiovascular system defects than infants of nondiabetic mothers. The absolute risk for infants of this group of diabetic mothers was 9.7%. No statistically significant differences were found among infants of mothers with gestational diabetes mellitus who did not require insulin during pregnancy.(ABSTRACT TRUNCATED AT 250 WORDS)